Effects of NEPA (novel combination of netupitant and palonosetron) on ECG of healthy volunteers: A randomized, controlled, thorough ECG trial.
Hizentra will be covered under the same Medicare benefit category as intravenous immune globulin (IVIg), but with the convenience of self-infusing at home KING OF PRUSSIA, Pa., June 8, 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback